SCHEMBL17951002

SCHEMBL17951002

CC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.53
MAPT P10636 1/20 0.53
THRB P10828 1/20 0.53
ALOX15 P16050 1/20 0.53
NFKB1 P19838 1/20 0.53
PTGS2 P35354 1/20 0.53
THPO P40225 1/20 0.53
RECQL P46063 1/20 0.53
BLM P54132 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ACE P12821 3/20 0.41
ALDH1A1 P00352 1/20 0.39
GNPAT O15228 1/20 0.35
SIRT5 Q9NXA8 1/20 0.34
MME P08473 4/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM1 P11229 1/20 0.33
FURIN P09958 3/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14753913 0.86 ACE (0.44) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL931282 0.85 KDM4E (0.57) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL18098148 0.85 KDM4E (0.57) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL18950367 0.84 MAPT (0.52) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL19934700 0.84 ACE (0.43) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL29392579 0.84 KDM4E (0.66) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL30493692 0.82 ALDH1A1 (0.56) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL17424360 0.82 SIRT5 (0.44) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL12035276 0.82 SIRT5 (0.44) SIRT5SIRT6SIRT1
SCHEMBL12354387 0.81 KDM4E (0.61) KDM4EMAPTTHRBALOX15NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016193514-A1 PEPTIDES DERIVED FROM S. AUREUS PEPTIDOGLYCAN AND USE THEREOF AS HAPTENS IN A DETECTION METHOD CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2016-12-08 WO disclosed
US-9453051-B2 Cyclosporin derivatives MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2016-09-27 US disclosed
EP-2751127-B1 CYCLOSPORIN DERIVATIVES MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V (DE) 2016-07-27 EP disclosed